Back

Temporal trends in guideline-directed medical therapy adoption in heart failure: insights from the iCaReMe global registry

28 August 2026 (09:50 - 10:00)
Organised by: Logo
Congress Presentation Part of: High-risk heart failure: when to optimise, when to escalate, when to support? Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ruben Oswaldo Silva Tinoco

Clinic Specialized in the Integral Management of Diabetes Iztapalapa, Ciudad de Mexico (Mexico)

4 More presentations in this session

Presentation thumbnail
Association between heart failure medical therapy and clinical outcomes after durable left ventricular assist device implantation
Doctor T. Kondo (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations
Doctor N. Sowden (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Benefit of betablockers in patients with heart failure and right ventricular dysfunction: insights from the FRESH multicentre study
Doctor C. Fauvel (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Pulmonary arterial elastance after LVAD implantation as a predictor of late right ventricular failure beyond six months of support
Mrs E. Karapedi (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
High-risk heart failure: when to optimise, when to escalate, when to support?
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 09:50 CET
You may be interested in
thumbnail
Congress Session
Implementing use of heart failure treatments in clinical practice
24 May 2022
thumbnail
Congress Presentation
Utilisation of guideline-directed medical therapy in the GRASP-HF study: patterns across acute and ambulatory heart failure settings
10 May 2026
thumbnail
Congress Presentation
Demographic, clinical and treatment patterns of patients with heart failure with reduced ejection fraction (HFrEF) in the Australian primary care setting
30 August 2025
thumbnail
Congress Session
Personalised therapy in heart failure
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources